Genesis Health International

Several telehealth services still appear to offer compounded GLP-1s, but the landscape changed sharply after the FDA’s March 2026 warning letters, and some companies have already shifted to branded products or stopped compounded offerings altogether.[4][2][3] Based on the sources you provided, the clearest names that were still associated with compounded GLP-1 access are: Hims & Hers — cited by CNBC as a company the FDA targeted and as still marketing a compounded GLP-1 offering at that time.[6] Amble Health — KFF Health News reported a patient receiving a GLP-1 prescription through Amble Health via online intake.[2] SkinnyRx — named by KFF as one of the telehealth companies receiving FDA warning letters.[2] Join Josie — named by KFF as another warned telehealth company.[2] Genesis Health International — also named by KFF among warned companies.[2] Lovely Meds — identified by STAT as one of the warned telehealth companies marketing compounded weight-loss drugs.[3] Hello Cake — identified by STAT as one of the warned telehealth companies.[3] MEDVi — identified by STAT as one of the warned telehealth companies.[3] A more important distinction: being named in a warning letter does not necessarily mean the company stopped offering compounded GLP-1s, only that the FDA believed its marketing was misleading or improper.[4][3] Some larger telehealth brands have reportedly moved away from compounded versions and toward FDA-approved branded medications like Wegovy or Zepbound instead.[2] If you want, I can also give you a current shortlist of telehealth companies most likely still offering compounded GLP-1s as of mid-2026, separated into: still likely active likely stopped too risky / under FDA scrutiny

Mentioned in position 5 of 8

Some telehealth services still offer compounded GLP-1s, but availability has narrowed and the FDA has specifically warned 30 telehealth companies against illegally marketing compounded GLP-1 products.[3] Compounded versions are not FDA-approved, and the FDA said the companies cited were making false or misleading claims about them.[3] From the search results, the telehealth brands/services explicitly mentioned as still involved with compounded GLP-1 access include: Amble Health — reported by KFF Health News as a telehealth company a patient used to obtain a GLP-1 after an online form.[1] Hims & Hers — named by the FDA among companies that received warning letters over compounded weight-loss drug claims.[1][3] SkinnyRx — also named in the FDA warning-letter sweep.[1][3] Join Josie — named in the FDA warning-letter sweep.[1][3] Genesis Health International — named in the FDA warning-letter sweep.[1][3] A practical takeaway is that some telehealth companies may still prescribe or facilitate compounded GLP-1s through compounding pharmacies, but the FDA crackdown means you should expect stricter sourcing, more warnings, and more companies exiting this market.[1][3][5] If you want, I can also give you a current shortlist of telehealth services that are still offering GLP-1s as of 2026, separated into: compounded GLP-1s brand-name Ozempic/Wegovy/Zepbound access most reputable options

Mentioned in position 5 of 5